Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.

× No keyword cloud information.

27 in total

1. Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas.

Authors: Alan Motta do Canto; Barbara Michaela Reis da Silva Marcelino; Juliana Lucena Schussel; Bruna F Wastner; Laurindo Moacir Sassi; Luciana Corrêa; Ronaldo Rodrigues de Freitas; Bengt Hasséus; Göran Kjeller; Celso Augusto Lemos Junior; Paulo Henrique Braz-Silva
Journal: Clin Oral Investig Date: 2018-05-31 Impact factor: 3.573

2. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.

Authors: John M Wright; Marilena Vered
Journal: Head Neck Pathol Date: 2017-02-28

3. [BRAF gene mutations in ameloblastic fibromas].

Authors: Z You; L L Xu; X F Li; J Y Zhang; J DU; L S Sun
Journal: Beijing Da Xue Xue Bao Yi Xue Ban Date: 2019-02-18

4. BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.

Authors: Adepitan A Owosho; Adeola M Ladeji; Kehinde E Adebiyi; Mofoluwaso A Olajide; Ikechukwu S I Okoye; Temitope Kehinde; Ngozi N Nwizu; Kurt F Summersgill
Journal: Eur Arch Otorhinolaryngol Date: 2020-11-24 Impact factor: 2.503

5. Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas-differences in mutation profiles in epithelial-derived oropharyngeal neoplasms.

Authors: Stephan Bartels; Akinyele Adisa; Timothy Aladelusi; Juliana Lemound; Angelika Stucki-Koch; Sami Hussein; Hans Kreipe; Christian Hartmann; Ulrich Lehmann; Kais Hussein
Journal: Virchows Arch Date: 2018-03-15 Impact factor: 4.064

Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.

1. Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas.

2. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors.

3. [BRAF gene mutations in ameloblastic fibromas].

4. BRAF V600E mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution.

5. Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas-differences in mutation profiles in epithelial-derived oropharyngeal neoplasms.

6. BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.

7. Molecular Signaling in Benign Odontogenic Neoplasia Pathogenesis.

8. Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy.

Review 9. ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.

10. Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.